Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Research & Development: 2014-2022

Historic Research & Development for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2022 value amounting to $4.0 million.

  • Collegium Pharmaceutical's Research & Development rose 35.94% to $4.0 million in Q1 2022 from the same period last year, while for Mar 2022 it was $10.5 million, marking a year-over-year increase of 4.66%. This contributed to the annual value of $4.0 million for FY2022, which is 57.86% down from last year.
  • According to the latest figures from FY2022, Collegium Pharmaceutical's Research & Development is $4.0 million, which was down 57.86% from $9.5 million recorded in FY2021.
  • In the past 5 years, Collegium Pharmaceutical's Research & Development registered a high of $10.3 million during FY2019, and its lowest value of $4.0 million during FY2022.
  • In the last 3 years, Collegium Pharmaceutical's Research & Development had a median value of $9.5 million in 2021 and averaged $7.7 million.
  • In the last 5 years, Collegium Pharmaceutical's Research & Development grew by 19.39% in 2019 and then slumped by 57.86% in 2022.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Research & Development stood at $8.7 million in 2018, then rose by 19.39% to $10.3 million in 2019, then declined by 5.49% to $9.8 million in 2020, then decreased by 3.28% to $9.5 million in 2021, then plummeted by 57.86% to $4.0 million in 2022.